Additional support for the role of immunoproteasomes in IBD comes from the demonstration that the expression of LMP2, one of the catalytic subunits of the immunoproteasome, was enhanced in colons of DSS-treated mice starting at early stages [64]. Here, PSMB9 is linked to irritable bowel syndrome.